A detailed history of Opal Wealth Advisors, LLC transactions in Alpha Tau Medical Ltd. stock. As of the latest transaction made, Opal Wealth Advisors, LLC holds 10,000 shares of DRTS stock, worth $30,700. This represents 0.01% of its overall portfolio holdings.

Number of Shares
10,000
Previous 10,000 -0.0%
Holding current value
$30,700
Previous $25,000 8.0%
% of portfolio
0.01%
Previous 0.01%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 03, 2023

BUY
$3.05 - $5.49 $30,500 - $54,900
10,000 New
10,000 $31,000

Others Institutions Holding DRTS

About Alpha Tau Medical Ltd.


  • Ticker DRTS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 69,011,296
  • Market Cap $212M
  • Description
  • Alpha Tau Medical Ltd., a clinical-stage oncology therapeutics company, engages in research, development, and commercialization of diffusing alpha-emitters radiation therapy (Alpha DaRT) for the treatment of solid cancer In Israel and the United States. Its Alpha-DaRT technology used in clinical trials for skin, oral, pancreatic, and breast canc...
More about DRTS
Track This Portfolio

Track Opal Wealth Advisors, LLC Portfolio

Follow Opal Wealth Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Opal Wealth Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Opal Wealth Advisors, LLC with notifications on news.